Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) EPS (Basic) (2021 - 2025)

Senti Biosciences has reported EPS (Basic) over the past 5 years, most recently at -$0.48 for Q4 2025.

  • Quarterly results put EPS (Basic) at -$0.48 for Q4 2025, up 22.58% from a year ago — trailing twelve months through Dec 2025 was -$3.14 (up 73.9% YoY), and the annual figure for FY2025 was -$2.73, up 77.31%.
  • EPS (Basic) for Q4 2025 was -$0.48 at Senti Biosciences, up from -$0.69 in the prior quarter.
  • Over the last five years, EPS (Basic) for SNTI hit a ceiling of $0.09 in Q4 2022 and a floor of -$8.24 in Q3 2023.
  • Median EPS (Basic) over the past 5 years was -$1.36 (2023), compared with a mean of -$2.18.
  • Peak annual rise in EPS (Basic) hit 106.8% in 2022, while the deepest fall reached 1578847.37% in 2022.
  • Senti Biosciences' EPS (Basic) stood at -$1.32 in 2021, then skyrocketed by 106.8% to $0.09 in 2022, then crashed by 1644.44% to -$1.39 in 2023, then skyrocketed by 55.4% to -$0.62 in 2024, then increased by 22.58% to -$0.48 in 2025.
  • The last three reported values for EPS (Basic) were -$0.48 (Q4 2025), -$0.69 (Q3 2025), and -$0.56 (Q2 2025) per Business Quant data.